Global Continuous Blood Glucose Monitoring Market Research Report 2024

Publication ID:

PB503244903

Publication Date:

March 15, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Continuous blood glucose monitoring system is a medical device which is used to track and monitor glucose levels in the blood. This system will help the patients to continuously track & monitor the fluctuations in the sugar level. The various components of continuous blood glucose monitoring system are insulin pumps, sensors, and transmitters and receivers among other to monitor it in real time.
The global Continuous Blood Glucose Monitoring market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North America region is expected to dominate the continuous blood glucose monitoring system market in the global arena due to growing FDA approvals and increase in number of diabetic patients in the US. However, rising economies of China & India and enhancing healthcare infrastructure in APAC is expected to boost the demand for continuous blood glucose monitoring system market in the future.
This report aims to provide a comprehensive presentation of the global market for Continuous Blood Glucose Monitoring, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Blood Glucose Monitoring.
Report Scope
The Continuous Blood Glucose Monitoring market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Continuous Blood Glucose Monitoring market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Blood Glucose Monitoring manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Lifescan
Medtronic
Bayer AG
Abbott
Terumo
Dexcom
Echo Therapeutics
B. Braun Melsungen
Arkray
Cellnovo Group
Nemaura
Tandem Diabetes Care
Segment by Type
Self-Monitoring Blood Glucose Systems
Continuous Glucose Monitoring Systems
Segment by Application
Hospitals
Clinics
Home Care
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Continuous Blood Glucose Monitoring manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Continuous Blood Glucose Monitoring in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Continuous Blood Glucose Monitoring Market Overview
1.1 Product Overview and Scope of Continuous Blood Glucose Monitoring
1.2 Continuous Blood Glucose Monitoring Segment by Type
1.2.1 Global Continuous Blood Glucose Monitoring Market Value Comparison by Type (2024-2030)
1.2.2 Self-Monitoring Blood Glucose Systems
1.2.3 Continuous Glucose Monitoring Systems
1.3 Continuous Blood Glucose Monitoring Segment by Application
1.3.1 Global Continuous Blood Glucose Monitoring Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Global Continuous Blood Glucose Monitoring Market Size Estimates and Forecasts
1.4.1 Global Continuous Blood Glucose Monitoring Revenue 2019-2030
1.4.2 Global Continuous Blood Glucose Monitoring Sales 2019-2030
1.4.3 Global Continuous Blood Glucose Monitoring Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Continuous Blood Glucose Monitoring Market Competition by Manufacturers
2.1 Global Continuous Blood Glucose Monitoring Sales Market Share by Manufacturers (2019-2024)
2.2 Global Continuous Blood Glucose Monitoring Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Continuous Blood Glucose Monitoring Average Price by Manufacturers (2019-2024)
2.4 Global Continuous Blood Glucose Monitoring Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Continuous Blood Glucose Monitoring, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Continuous Blood Glucose Monitoring, Product Type & Application
2.7 Continuous Blood Glucose Monitoring Market Competitive Situation and Trends
2.7.1 Continuous Blood Glucose Monitoring Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Continuous Blood Glucose Monitoring Players Market Share by Revenue
2.7.3 Global Continuous Blood Glucose Monitoring Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Continuous Blood Glucose Monitoring Retrospective Market Scenario by Region
3.1 Global Continuous Blood Glucose Monitoring Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Continuous Blood Glucose Monitoring Global Continuous Blood Glucose Monitoring Sales by Region: 2019-2030
3.2.1 Global Continuous Blood Glucose Monitoring Sales by Region: 2019-2024
3.2.2 Global Continuous Blood Glucose Monitoring Sales by Region: 2025-2030
3.3 Global Continuous Blood Glucose Monitoring Global Continuous Blood Glucose Monitoring Revenue by Region: 2019-2030
3.3.1 Global Continuous Blood Glucose Monitoring Revenue by Region: 2019-2024
3.3.2 Global Continuous Blood Glucose Monitoring Revenue by Region: 2025-2030
3.4 North America Continuous Blood Glucose Monitoring Market Facts & Figures by Country
3.4.1 North America Continuous Blood Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Continuous Blood Glucose Monitoring Sales by Country (2019-2030)
3.4.3 North America Continuous Blood Glucose Monitoring Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Continuous Blood Glucose Monitoring Market Facts & Figures by Country
3.5.1 Europe Continuous Blood Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Continuous Blood Glucose Monitoring Sales by Country (2019-2030)
3.5.3 Europe Continuous Blood Glucose Monitoring Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Continuous Blood Glucose Monitoring Market Facts & Figures by Country
3.6.1 Asia Pacific Continuous Blood Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Continuous Blood Glucose Monitoring Sales by Country (2019-2030)
3.6.3 Asia Pacific Continuous Blood Glucose Monitoring Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Continuous Blood Glucose Monitoring Market Facts & Figures by Country
3.7.1 Latin America Continuous Blood Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Continuous Blood Glucose Monitoring Sales by Country (2019-2030)
3.7.3 Latin America Continuous Blood Glucose Monitoring Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Continuous Blood Glucose Monitoring Market Facts & Figures by Country
3.8.1 Middle East and Africa Continuous Blood Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Continuous Blood Glucose Monitoring Sales by Country (2019-2030)
3.8.3 Middle East and Africa Continuous Blood Glucose Monitoring Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Continuous Blood Glucose Monitoring Sales by Type (2019-2030)
4.1.1 Global Continuous Blood Glucose Monitoring Sales by Type (2019-2024)
4.1.2 Global Continuous Blood Glucose Monitoring Sales by Type (2025-2030)
4.1.3 Global Continuous Blood Glucose Monitoring Sales Market Share by Type (2019-2030)
4.2 Global Continuous Blood Glucose Monitoring Revenue by Type (2019-2030)
4.2.1 Global Continuous Blood Glucose Monitoring Revenue by Type (2019-2024)
4.2.2 Global Continuous Blood Glucose Monitoring Revenue by Type (2025-2030)
4.2.3 Global Continuous Blood Glucose Monitoring Revenue Market Share by Type (2019-2030)
4.3 Global Continuous Blood Glucose Monitoring Price by Type (2019-2030)
5 Segment by Application
5.1 Global Continuous Blood Glucose Monitoring Sales by Application (2019-2030)
5.1.1 Global Continuous Blood Glucose Monitoring Sales by Application (2019-2024)
5.1.2 Global Continuous Blood Glucose Monitoring Sales by Application (2025-2030)
5.1.3 Global Continuous Blood Glucose Monitoring Sales Market Share by Application (2019-2030)
5.2 Global Continuous Blood Glucose Monitoring Revenue by Application (2019-2030)
5.2.1 Global Continuous Blood Glucose Monitoring Revenue by Application (2019-2024)
5.2.2 Global Continuous Blood Glucose Monitoring Revenue by Application (2025-2030)
5.2.3 Global Continuous Blood Glucose Monitoring Revenue Market Share by Application (2019-2030)
5.3 Global Continuous Blood Glucose Monitoring Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Continuous Blood Glucose Monitoring Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Lifescan
6.2.1 Lifescan Corporation Information
6.2.2 Lifescan Description and Business Overview
6.2.3 Lifescan Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Lifescan Continuous Blood Glucose Monitoring Product Portfolio
6.2.5 Lifescan Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Medtronic Continuous Blood Glucose Monitoring Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Bayer AG
6.4.1 Bayer AG Corporation Information
6.4.2 Bayer AG Description and Business Overview
6.4.3 Bayer AG Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer AG Continuous Blood Glucose Monitoring Product Portfolio
6.4.5 Bayer AG Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Corporation Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Abbott Continuous Blood Glucose Monitoring Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 Terumo
6.6.1 Terumo Corporation Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Terumo Continuous Blood Glucose Monitoring Product Portfolio
6.6.5 Terumo Recent Developments/Updates
6.7 Dexcom
6.6.1 Dexcom Corporation Information
6.6.2 Dexcom Description and Business Overview
6.6.3 Dexcom Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dexcom Continuous Blood Glucose Monitoring Product Portfolio
6.7.5 Dexcom Recent Developments/Updates
6.8 Echo Therapeutics
6.8.1 Echo Therapeutics Corporation Information
6.8.2 Echo Therapeutics Description and Business Overview
6.8.3 Echo Therapeutics Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Echo Therapeutics Continuous Blood Glucose Monitoring Product Portfolio
6.8.5 Echo Therapeutics Recent Developments/Updates
6.9 B. Braun Melsungen
6.9.1 B. Braun Melsungen Corporation Information
6.9.2 B. Braun Melsungen Description and Business Overview
6.9.3 B. Braun Melsungen Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.9.4 B. Braun Melsungen Continuous Blood Glucose Monitoring Product Portfolio
6.9.5 B. Braun Melsungen Recent Developments/Updates
6.10 Arkray
6.10.1 Arkray Corporation Information
6.10.2 Arkray Description and Business Overview
6.10.3 Arkray Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Arkray Continuous Blood Glucose Monitoring Product Portfolio
6.10.5 Arkray Recent Developments/Updates
6.11 Cellnovo Group
6.11.1 Cellnovo Group Corporation Information
6.11.2 Cellnovo Group Continuous Blood Glucose Monitoring Description and Business Overview
6.11.3 Cellnovo Group Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Cellnovo Group Continuous Blood Glucose Monitoring Product Portfolio
6.11.5 Cellnovo Group Recent Developments/Updates
6.12 Nemaura
6.12.1 Nemaura Corporation Information
6.12.2 Nemaura Continuous Blood Glucose Monitoring Description and Business Overview
6.12.3 Nemaura Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Nemaura Continuous Blood Glucose Monitoring Product Portfolio
6.12.5 Nemaura Recent Developments/Updates
6.13 Tandem Diabetes Care
6.13.1 Tandem Diabetes Care Corporation Information
6.13.2 Tandem Diabetes Care Continuous Blood Glucose Monitoring Description and Business Overview
6.13.3 Tandem Diabetes Care Continuous Blood Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Tandem Diabetes Care Continuous Blood Glucose Monitoring Product Portfolio
6.13.5 Tandem Diabetes Care Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Continuous Blood Glucose Monitoring Industry Chain Analysis
7.2 Continuous Blood Glucose Monitoring Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Continuous Blood Glucose Monitoring Production Mode & Process
7.4 Continuous Blood Glucose Monitoring Sales and Marketing
7.4.1 Continuous Blood Glucose Monitoring Sales Channels
7.4.2 Continuous Blood Glucose Monitoring Distributors
7.5 Continuous Blood Glucose Monitoring Customers
8 Continuous Blood Glucose Monitoring Market Dynamics
8.1 Continuous Blood Glucose Monitoring Industry Trends
8.2 Continuous Blood Glucose Monitoring Market Drivers
8.3 Continuous Blood Glucose Monitoring Market Challenges
8.4 Continuous Blood Glucose Monitoring Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Roche
Lifescan
Medtronic
Bayer AG
Abbott
Terumo
Dexcom
Echo Therapeutics
B. Braun Melsungen
Arkray
Cellnovo Group
Nemaura
Tandem Diabetes Care

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂